Kaiser Permanente-Irvine — Irvine, California

Public research footprint of Kaiser Permanente-Irvine, compiled from the ClinicalTrials.gov public registry.

144

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Stage IB Lung Non-Small Cell Carcinoma AJCC v7 · Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma · Recurrent Ovarian Carcinoma · Chronic Lymphocytic Leukemia

Recently updated registry entries

NCT07061977 — Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation… (Recruiting)
NCT04269902 — Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or… (Recruiting)
NCT04267848 — Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Kaiser Permanente-Irvine?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.